08.01.2015 Views

1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

2003 Meeting 16 September CSM and<br />

Expert group on Safety of <strong>SSRI</strong>s<br />

2003 Committee on Safety of Medicines<br />

and Expert Group on Safety of <strong>SSRI</strong>s.<br />

Minutes of the meeting held Tuesday 25<br />

November 2003.<br />

http://www.mhra.gov.uk/home/groups/plp/documents/committeedocument/con003487.pdf<br />

2003 Interim report of the Committee on Safety<br />

of Medicines´ Expert Working Group on<br />

<strong>Selective</strong> Serotonin Reuptake Inhibitors<br />

September 2003<br />

2003 WHO Pharmaceutical Newsletter 2003; no 1.<br />

Drugs of abuse: Problems of data collection,<br />

definitions and liability assessment.<br />

drugs for which<br />

drug dependence<br />

has ever been<br />

reported to the<br />

Uppsala Monitoring<br />

Centre database.<br />

The group Minutes<br />

expressed concern<br />

about the lack of<br />

data on the longtern<br />

effect of <strong>SSRI</strong>s<br />

and recommended<br />

that further research<br />

on this area was<br />

required.<br />

Professor<br />

Minutes<br />

Drummond<br />

explained that he<br />

had considered to<br />

what extent the<br />

<strong>SSRI</strong>s meet the<br />

ICD-10 and DSM-<br />

IV definitions of<br />

dependence and has<br />

concluded that the<br />

extent to which<br />

<strong>SSRI</strong>s meet the<br />

criteria is much less<br />

than with other<br />

typically<br />

dependence<br />

producing drugs.<br />

Two areas of Report<br />

continual concern<br />

…. and <strong>withdrawal</strong><br />

reactions on<br />

stopping <strong>SSRI</strong>s.<br />

However, such a Newsletter<br />

conclusion may<br />

only be drawn after<br />

a careful review of<br />

the significant<br />

number of “drug<br />

dependence” reports<br />

for <strong>SSRI</strong>s received<br />

by the ADR<br />

monitoring system<br />

and, not on the basis

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!